DSM N.V. : DSM acquires Microbia, Inc. to expand its leading position in specialty ingredients
* Reuters is not responsible for the content in this press release.
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the acquisition of Microbia, Inc. (Lexington, Massachusetts, United States) from Ironwood Pharmaceuticals, Inc. The terms of the acquisition will not be disclosed. Microbia is a successful industrial biotechnology research and development specialist. It has developed a highly effective technology platform that enables it to produce high-quality, natural carotenoids (including β-carotene and canthaxanthin), nutritional products and other specialty materials and chemicals from renewable resources. Microbia's sales are still limited. The acquisition will allow DSM to incorporate Microbia's proprietary platform and world class research and development capabilities and support DSM's ongoing development of the natural carotenoids market. Leendert Staal, President and CEO of DSM Nutritional Products commented: "The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes. This acquisition allows us to expand our product portfolio as well as our research and development capabilities." Kevin Madden, Chief Science Officer of Microbia added, "We are thrilled to join DSM. Being part of a large global organization, and a world leader in industrial biotechnology, vitamins and carotenoid development, manufacturing and sales will expedite our ability to leverage our proprietary bio-based technology platform. We look forward to help accelerate DSM's ongoing efforts to develop, produce and commercialize the next generation of nutritional ingredients and other materials that will help the food, feed, chemicals and other industries produce more innovative and sustainable products, in a far more cost effective and responsible manner." About Microbia Microbia, Inc. (formerly Microbia Precision Engineering) is an industrial biotechnology company applying proprietary metabolic engineering utilizing fermentation technology to create natural, cost-effective, renewable specialty ingredients and biomaterials. About DSM Nutritional Products DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com http://www.dsmnutritionalproducts.com/ DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about €8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations http://www.dsm.com/en_US/html/about/location_finder.htm on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com http://www.dsm.com/ For more information: DSM Corporate Communications Herman Betten DSM Investor Relations Hans Vossen tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864 fax +31 (0) 45 5740680 fax +31 (0) 10 4590275 e-mail email@example.com mailto:firstname.lastname@example.org e-mail email@example.com mailto:firstname.lastname@example.org DSM Investor Relations Hans Vossen tel. +31 (0) 45 5782864 fax +31 (0) 10 4590275 e-mail email@example.com mailto:firstname.lastname@example.org HUG#1445921 Press release-pdf http://hugin.info/130663/R/1445921/389029.pdf